首页|多索茶碱辅助无创呼吸机治疗慢性阻塞性肺疾病急性加重期合并呼吸衰竭的疗效观察

多索茶碱辅助无创呼吸机治疗慢性阻塞性肺疾病急性加重期合并呼吸衰竭的疗效观察

扫码查看
目的 探究多索茶碱辅助无创呼吸机治疗慢性阻塞性肺疾病急性加重期(AECOPD)合并呼吸衰竭的临床效果,以及对血气指标、肺功能及辅助性T细胞(Th17)、调节性T细胞(Treg)的影响。方法 纳入2019年1月至2022年12月皖西卫生职业学院附属医院收治的60例AECOPD合并呼吸衰竭患者,在保证组间基线特征具有可比性的原则上,采用随机数字表法分为对照组(n=30)和观察组(n=30),对照组给予无创呼吸机治疗,观察组在对照组的基础上辅助多索茶碱治疗,连续治疗7 d。比较两组患者的临床疗效、血气指标、肺功能指标,以及Th17、Treg水平及术后不良反应发生情况。结果 观察组临床总有效率(93。33%)高于对照组(70。00%),差异有统计学意义(P<0。05)。治疗前,两组患者血pH、动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)等血气指标及用力肺活量(FVC)、第一秒用力呼气容积(FEV1)或呼气流量峰值(PEF)等肺功能指标比较差异均无统计学意义(P>0。05)。治疗后,两组患者的血pH、PaO2及肺功能指标均升高,且观察组高于对照组,两组患者的PaCO2均降低,且观察组低于对照组,差异有统计学意义(P<0。05)。治疗前,两组患者的Th17、Treg水平比较差异无统计学意义(P>0。05);治疗后,两组患者的Th17水平均降低,且观察组低于对照组,Treg水平均升高,且观察组高于对照组,差异有统计学意义(P<0。05)。两组患者的不良反应总发生率比较差异无统计学意义(P>0。05)。结论 AECOPD合并呼吸衰竭患者应用多索茶碱辅助无创呼吸机治疗效果显著,可改善血气指标和肺功能,调节Th17、Treg水平,且安全性良好。
Efficacy of doxofylline assisted non-invasive ventilator in the treatment of acute exacerbation of chronic obstructive pulmonary disease complicated with respiratory failure
Objective To investigate the clinical effect of doxofylline assisted non-invasive ventilator in the treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD)complicated with respiratory failure,and the influence on blood gas indexes,respiratory function,T helper 17(Th17)cells and regulatory T(Treg)cells.Method Sixty patients with AECOPD complicated with respiratory failure were admitted to the Affiliated Hospital of West Anhui Health Vocational College from January 2019 to December 2022.The subjects were divided into control group(n=30)and observation group(n=30)by random number table method.The control group was treated with non-invasive ventilator,while the observation group was treated with doxofylline on the above basis for 7 consecutive days.The clinical effect,blood gas indexes,respiratory function,levels of Th17 cells and Treg cells,and incidence of adverse reactions were compared between the groups.Result The total clinical response rate in observation group(93.33%)was higher than that in control group(70.00%)(P<0.05).There was no significant difference in blood gas indexes[blood pH value,arterial partial pressure of oxygen(PaO2),and arterial partial pressure of carbon dioxide(PaCO2)]or pulmonary function indicators[forced vital capacity(FVC),forced expiratory volume in 1 second(FEV1)and peak expiratory flow(PEF)]between the groups before treatment(P>0.05).After treatment,there were increases in pH values,PaO2 and pulmonary function indicators in both groups,and these indicators in observation group were higher than those in control group.There were decreases in PaCO2 in both groups,and PaCO2 in observation group was lower than that in control group.The differences between groups were statistically significant(P<0.05).There was no statistically significant difference in the levels of Th17 cells and Treg cells between the groups before treatment(P>0.05).After treatment,there were decreases in Th17 cells levels in both groups,and the level in observation group was lower than that in control group.There were increases in Treg cells levels,and the level in observation group was higher than that in control group.The differences between groups were statistically significant(P<0.05).There was no statistically significant difference in the total incidence of adverse reactions between the two groups(P>0.05).Conclusion Doxofylline assisted non-invasive ventilator was effective in the treatment of AECOPD complicated with respiratory failure,which could improve blood gas indexes,respiratory function,and regulate the levels of Th17 cells and Treg cells,with good safety.

Acute exacerbation of chronic obstructive pulmonary diseaseRespiratory failureDoxophyllineNon-invasive ventilatorBlood gas index

杨传亮、张谷香、刘汉辰

展开 >

皖西卫生职业学院附属医院急诊科,安徽 六安 237000

皖西卫生职业学院附属医院呼吸内科,安徽 六安 237000

慢性阻塞性肺疾病急性加重期 呼吸衰竭 多索茶碱 无创呼吸机 血气指标

安徽省卫生健康委科研项目

AHWJ2021a072

2024

中国医刊
人民卫生出版社

中国医刊

CSTPCD
影响因子:1.14
ISSN:1008-1070
年,卷(期):2024.59(7)